1. Are We Making Progress in the Management of Huntington Disease?

3. Program Overview

4. Burden of HD on Patients

5. Burden of HD on Patients (cont)

6. Burden of HD on Caregivers and Society

7. Treatments for HD

8. Deutetrabenazine: FIRST-HD Trial

9. Deutetrabenazine: Safety Profile

10. Deutetrabenazine: Impact on Patient

11. Pridopidine: Control of Voluntary Motor Coordination in HD

12. Pridopidine: PRIDE-HD Study

13. Potential Impact of Improvements in One Symptom on Other Symptoms

14. The Role of PCPs in Treating HD

15. The Role of PCPs in Treating HD (cont)

16. Strategies for Developing New HD Therapies

17. Strategies for Developing New HD Therapies (cont)

18. Structural Changes in Brain Prior to Emergence of HD Symptoms

19. Future Developments in HD Treatment

20. Concluding Remarks

21. Concluding Remarks (cont)

22. Abbreviations